Literature DB >> 17384341

Initiate Insulin by Aggressive Titration and Education (INITIATE): a randomized study to compare initiation of insulin combination therapy in type 2 diabetic patients individually and in groups.

Hannele Yki-Järvinen1, Leena Juurinen, Michael Alvarsson, Tord Bystedt, Ian Caldwell, Melanie Davies, Sanni Lahdenperä, Gil Nijpels, Markku Vähätalo.   

Abstract

OBJECTIVE: Insulin is often postponed for years because initiation is time-consuming. We sought to compare initiation of insulin individually and in groups with respect to change in A1C and several other parameters in type 2 diabetic patients. RESEARCH DESIGN AND METHODS: A randomized (1:1), multicenter, two-arm, parallel design study with a recruiting period of up to 14 weeks and a 24-week treatment period. Either in groups of 4-8 or individually, using the same personnel and education program, 121 insulin-naive type 2 diabetic patients with an A1C of 7.0-12.0% were randomized to initiate bedtime insulin glargine. The patients visited the treatment center before and at the time of insulin initiation and at 6, 12, and 24 weeks. Patients self-adjusted the insulin dose to achieve a fasting plasma glucose 4.0-5.5 mmol/l.
RESULTS: At 24 weeks, mean +/- SE A1C had decreased from 8.7 +/- 0.2 to 6.9 +/- 0.1% in those treated individually and from 8.8 +/- 0.2 to 6.8 +/- 0.1% in those in groups (not significant [NS]). Insulin doses averaged 62 +/- 5 IU and 56 +/- 5 IU at 24 weeks (NS), respectively. The frequency of hypoglycemia was similar. The total time (visits and phone calls) spent in initiating insulin in the patients in groups (2.2 +/- 0.1 h) was 48% less than in those treated individually (4.2 +/- 0.2 h). Diabetes treatment satisfaction improved significantly in both sets of patients.
CONCLUSIONS: Similar glycemic control and treatment satisfaction can be achieved by initiating insulin in groups and individually. Starting insulin in groups takes one-half as much time as individual initiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17384341     DOI: 10.2337/dc06-1357

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  38 in total

1.  Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  S E Inzucchi; R M Bergenstal; J B Buse; M Diamant; E Ferrannini; M Nauck; A L Peters; A Tsapas; R Wender; D R Matthews
Journal:  Diabetologia       Date:  2012-04-20       Impact factor: 10.122

Review 2.  Initiating insulin in patients with type 2 diabetes.

Authors:  Adrian N C Lau; Terence Tang; Henry Halapy; Kevin Thorpe; Catherine H Y Yu
Journal:  CMAJ       Date:  2012-04-02       Impact factor: 8.262

Review 3.  Basal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision making.

Authors:  Gerhard H Scholz; Holger Fleischmann
Journal:  Ther Adv Endocrinol Metab       Date:  2014-10       Impact factor: 3.565

Review 4.  Relationship of insulin dose, A1c lowering, and weight in type 2 diabetes: comparing insulin glargine and insulin detemir.

Authors:  George Dailey; Karim Admane; Florence Mercier; David Owens
Journal:  Diabetes Technol Ther       Date:  2010-12       Impact factor: 6.118

5.  Clinical Considerations for Insulin Pharmacotherapy in Ambulatory Care, Part One: Introduction and Review of Current Products and Guidelines.

Authors:  John A Galdo; Maria Miller Thurston; Catherine A Bourg
Journal:  Clin Diabetes       Date:  2014-04

6.  Treat-to-target insulin titration algorithms when initiating long or intermediate acting insulin in type 2 diabetes.

Authors:  Poul Strange
Journal:  J Diabetes Sci Technol       Date:  2007-07

Review 7.  Common standards of basal insulin titration in type 2 diabetes.

Authors:  Sabine Arnolds; Tim Heise; Frank Flacke; Jochen Sieber
Journal:  J Diabetes Sci Technol       Date:  2013-05-01

8.  Practical Guidance on Effective Basal Insulin Titration for Primary Care Providers.

Authors:  Louis Kuritzky; Timothy S Reid; Carol H Wysham
Journal:  Clin Diabetes       Date:  2019-10

9.  Fasting plasma glucose 6-12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysis.

Authors:  D Karl; R Zhou; A Vlajnic; M Riddle
Journal:  Diabet Med       Date:  2012-07       Impact factor: 4.359

10.  The consequences of delaying insulin initiation in UK type 2 diabetes patients failing oral hyperglycaemic agents: a modelling study.

Authors:  Gordon Goodall; Eric M Sarpong; Clarice Hayes; William J Valentine
Journal:  BMC Endocr Disord       Date:  2009-10-05       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.